Joji Iida
Overview
Explore the profile of Joji Iida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dorchak J, Maria S, Guarinoni J, Duensing A, Somiari S, Cavanaugh J, et al.
Horm Cancer
. 2018 Apr;
9(4):240-253.
PMID: 29687205
This retrospective case series study, using data obtained through questionnaires and histopathological diagnoses from 656 patients enrolled in the Department of Defense (DoD) Clinical Breast Care Project (CBCP), evaluated associations...
2.
Iida J, Bell-Loncella E, Purazo M, Lu Y, Dorchak J, Clancy R, et al.
J Transl Med
. 2016 Feb;
14:48.
PMID: 26867596
Background: Previous studies suggest that certain transition metal complexes, such as cisplatin, are efficacious for treating various cancer types, including ovarian, lung, and breast. Methods: In order to further evaluate...
3.
Li R, Campos J, Iida J
Genetics
. 2015 Oct;
201(4):1341-8.
PMID: 26510790
Molecular heterogeneity in human breast cancer has challenged diagnosis, prognosis, and clinical treatment. It is well known that molecular subtypes of breast tumors are associated with significant differences in prognosis...
4.
Iida J, Dorchak J, Clancy R, Slavik J, Ellsworth R, Katagiri Y, et al.
Exp Cell Res
. 2014 Dec;
330(2):358-370.
PMID: 25445787
There are lines of evidence demonstrating that NEDD9 (Cas-L, HEF-1) plays a key role in the development, progression, and metastasis of breast cancer cells. We previously reported that NEDD9 plays...
5.
Iida J, Clancy R, Dorchak J, Somiari R, Somiari S, Cutler M, et al.
PLoS One
. 2014 Mar;
9(2):e88712.
PMID: 24586375
CD44 adhesion molecules are expressed in many breast cancer cells and have been demonstrated to play a key role in regulating malignant phenotypes such as growth, migration, and invasion. CD44...
6.
Iida J, Dorchak J, Lehman J, Clancy R, Luo C, Chen Y, et al.
PLoS One
. 2012 Sep;
7(9):e44418.
PMID: 22984505
There is substantial evidence indicating that the WNT signaling pathway is activated in various cancer cell types including breast cancer. Previous studies reported that FH535, a small molecule inhibitor of...
7.
Goda S, Kaneshita Y, Inoue H, Domae E, Ikeo T, Iida J, et al.
J Periodontol
. 2009 Oct;
80(10):1631-7.
PMID: 19792853
Background: Enamel matrix derivative (EMD) protein has been clinically used for periodontal regeneration, but the molecular mechanisms are not clear. Previous studies suggested that the activation of phosphoinositide 3-kinase (PI...
8.
Dunn K, Lee P, Wilson C, Iida J, Wasiluk K, Hugger M, et al.
Surgery
. 2009 Feb;
145(3):322-9.
PMID: 19231585
Introduction: Hyaluronan (HA) and its biosynthetic enzymes hyaluronan synthases (HAS2 and HAS3) mediate Matrigel invasion by SW620 colon carcinoma cells. Because matrix metalloproteinases (MMPs) have been implicated in cancer invasion,...
9.
Iida J, McCarthy J
Melanoma Res
. 2007 Jul;
17(4):205-13.
PMID: 17625450
Tumor cell invasion through basement membranes and into stromal tissue are key steps for promoting growth and metastasis. Tumor cells express various extracellular-matrix-degrading enzymes such as matrix metalloproteinases (MMPs) to...
10.
Iida J, Wilhelmson K, Ng J, Lee P, Morrison C, Tam E, et al.
Biochem J
. 2007 Jan;
403(3):553-63.
PMID: 17217338
We previously reported that CS (chondroitin sulfate) GAG (glycosaminoglycan), expressed on MCSP (melanoma-specific CS proteoglycan), is important for regulating MT3-MMP [membrane-type 3 MMP (matrix metalloproteinase)]-mediated human melanoma invasion and gelatinolytic...